Zentalis Pharmaceuticals Revenue, Growth & Competitor Profile

Company Profile & Annual Report for Zentalis Pharmaceuticals

Access the complete profile.

Zentalis Pharmaceuticals Fast Facts

Revenue	$100 - $500 million    See Exact Annual Revenue
Employees	100 - 500Exact Company Size
Primary Industry	325411 Medicinal & Botanical Manufacturing
Address	10275 Science Center Dr. Suite 200 San Diego, CA 92121

Note: Revenues for privately held companies are statistical evaluations.


Zentalis Pharmaceuticals's Annual Report & Profile shows critical firmographic facts:

• What is the company's size? (Annual sales and employees)
  • Zentalis Pharmaceuticals's annual revenues are $100 - $500 million (see exact revenue data)
• What industry is the company in?
  • Zentalis Pharmaceuticals is classified as operating in the Medicinal & Botanical Manufacturing industry, NAICS Code 325411.

Zentalis Pharmaceuticals Annual Revenue and Growth Rate

Zentalis Pharmaceuticals	Revenue Est. ($ Million)	Growth Rate (%)	# Employees
2023	$100 - $500 million Details in Premium Report
2022
2021
2020
2019

1-Year Growth Rate: 3-Year Growth Rate (CAGR):

Note: Zentalis Pharmaceuticals's revenues are gauged from an analysis of company filings.

Zentalis Pharmaceuticals's Income Statement (based on Industry Averages)

Zentalis Pharmaceuticals P&L	$ Millions
Revenue (Sales)
Cost of Goods Sold
Gross Profit
Operating Expenses
Advertising
Salaries and wages
Other Operating Expenses
Total Operating Expenses
Operating Income
EBITDA
EBIT (Earnings Before Interest and Taxes)
Net Profit

Trademark Applications

Trademark applications show the products and services that Zentalis Pharmaceuticals is developing and marketing. Zentalis Pharmaceuticals doesn't have any recent trademark applications, indicating Zentalis Pharmaceuticals is focusing on its existing business rather than expanding into new products and markets. Trademarks may include brand names, product names, logos and slogans.

Trademark	Date
XYTALYS Pharmaceuticals, pharmaceutical preparations and substances for the prevention and treatment of cancer, auto-immune diseases, and infectious diseases; Chemical preparations for pharmaceutical or medical purposes, namely, for the prevention and treatment of cancer, auto-immune diseases, and infectious diseases	07/12/2022
WEEONZA Pharmaceuticals, pharmaceutical preparations and substances for the prevention and treatment of cancer, auto-immune diseases, and infectious diseases; Chemical preparations for pharmaceutical or medical purposes, namely, for the prevention and treatment of cancer, auto-immune diseases, and infectious diseases	07/12/2022
FULL STACK DISCOVERY ENGINE Providing scientific, pharmaceutical, clinical, and medical research information via the internet; research and development of new products; drug discovery, development, and validation services; pharmaceutical, scientific, medical and clinical research and development services; consulting services in the field of pharmaceutical assessment; validation, screening and mapping of material for drug discovery purposes; providing scientific information and medical research information in the fields of pharmaceuticals, biology, chemistry, biochemistry, biotechnology, and clinical trials; research and development in the fields of cancer, infectious diseases, autoimmune diseases, and in the prevention and treatment of pain; providing online information in the fields of cancer, infectious diseases, autoimmune diseases, pharmaceuticals, biology, chemistry, biochemistry, biotechnology, and clinical trials, and the prevention and treatment of pain, by means of a website; providing information, scientific, pharmaceutical, clinical, and medical research, drug discovery, development and validation, and consulting services with respect to differentiated small molecules used for the treatment of cancer, infectious diseases, autoimmune diseases, and in the prevention and treatment of pain	03/26/2021

See all trademarks and details in the Full Report.

Market Share of Zentalis Pharmaceuticals's Largest Competitors

A competitive analysis shows these companies are in the same general field as Zentalis Pharmaceuticals, even though they may not compete head-to-head. These are the largest companies by revenue. However, they may not have the largest market share in this industry if they have diversified into other business lines. The "Competition" section of a business plan or investment memorandum would start by analyzing the information about these companies. Competitive advantage comes from offering better pricing or superior products/service.

Company	Headquarters	Revenue ($ MM)
XYMOGEN	Orlando, FL	100
AVANTI NUTRITIONAL LABORATORIES	Miami Lakes, FL	37
NUTRITION FORMULATORS	Miramar, FL	36
RTPR	Cabot, AR	33
INTEGRATED BOTANICS	Fort Worth, TX	29
COSMAX NBT USA	Garland, TX	29
CJB INDUSTRIES	Valdosta, GA	28
ALTERNATIVE LABORATORIES	Naples, FL	28
S&B PHARMA	Azusa, CA	28

Nearby Competitors

These companies are similar in business line and location to Zentalis Pharmaceuticals. While some companies compete with neighboring businesses for customers, other companies may compete to attract skilled employees.

Company	Headquarters	Revenue ($ MM)
MARAVAI INTERMEDIATE HOLDINGS	San Diego, CA	100
CUE HEALTH	San Diego, CA	95
AJINOMOTO ALTHEA	San Diego, CA	73
NEURELIS	San Diego, CA	20
ZENTALIS PHARMACEUTICALS	San Diego, CA	18
PLEXIUM	San Diego, CA	14

Future Competition: Zentalis Pharmaceuticals's Fastest Growing Competitors

These companies are in the same general field as Zentalis Pharmaceuticals and are rapidly expanding. Companies may grow organically or through acquisition. In some cases apparently high growth rates may be caused by data that weren't available in previous years.

Company	Revenue ($ MM)